Latest Market Research Report 2025

  The global  companion animal medicine market  size is expected to reach USD 41.18 billion by 2030 and is expected to expand at 9.9% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The key factors driving the growth of the market for companion animal medicine include the rising pet population, the increased prevalence of diseases, and the availability of pet insurance.   In Canada for example, more than half of the country’s households (around 60% of households) owned at least one dog or cat in 2022, according to the Canadian Animal Health Institute (CAHI). The country’s dog population increased from 7.7 million in 2020 to 7.9 million in 2022, whereas the cat population increased from 8.1 million in 2020 to 8.5 million in 2022. CAHI also reported a surge in feline vet visits following the start of the COVID-19 outbreak in 2020. The COVID-19 pandemic notably affected the market for companion animal medicine. The impact included dampened...

  Companion Animal Medicine Industry Overview The global companion animal medicine market size was valued at USD 15.8 billion in 2020 and is estimated to expand at a compound annual growth rate (CAGR) of 9.6% from 2021 to 2028.   Increasing prevalence of diseases in pets, rising pet expenditure, humanization of pets, adoption of online channels for buying pet medicines, and initiatives by key companies are the factors anticipated to fuel the market in the coming years. According to a 2021 article in the BMC Veterinary Research Journal, for instance, the prevalence of dental disorders diagnosed in dogs in the U.K. was found to be 14.10% and skin disorders were found to be 12.6%.   Gather more insights about the market drivers, restrains and growth of the Global Companion Animal Medicine Market   The COVID-19 outbreak notably impacted the market. Some of the adverse effects included low demand, supply chain disruptions, hurdles in research activities, and dampen...